Category Specific RSS

kilian kelly

Cynata recruits first patient for Phase 2 trial of stem cells for graft vs host disease

Aussie clinical stage biotech company Cynata Therapeutics (ASX: CYP) has marked a milestone in its Phase 2 clinical trial of…

1 year ago

Cynata Therapeutics advances Stem Cell Therapy for rare disease with Phase 2 recruitment underway

If you key in the word “stem cell" into a search engine, results will show they have the potential to…

2 years ago

Cynata to tackle common transplant side effect with lead drug CYP-001

The first successful organ donation occurred in 1954 where a living donor gave a kidney to his identical twin. Since…

3 years ago

Body of evidence grows for Cynata’s stem cell production platform

“Published” is an accolade that many scientists strive for. Showcasing your work and communicating your results to peers feels good,…

4 years ago